Site MapCompany InformationContact Us
 

WhoCanISue.comPharmaceuticalNeurontin

Learn More About Neurontin Claims

 
Summary

Neurontin (gabapentin) is an anticonvulsant drug, formerly manufactured by Parke-Davis (a division of Warner Lambert which, in 2000, was acquired by Pfizer). When it was first introduced in 1994, Neurontin was FDA approved for two uses: 1/ the control of partial seizures associated with epilepsy and 2/ the management of postherpetic neuralgia (PHN) following an outbreak of shingles (herpes zoster). 

It was actually Neurontin’s off-label uses, however, which accounted for nearly 90% of its revenue – which was $97.5 million in 1995, rising to $2.7 billion by 2003.

As Neurontin’s sales rose, it became Pfizer’s top selling drug. More than 10 million U.S. prescriptions for Neurontin have been filled since 1996. The drug is available in 100, 300 400, 600 and 800 mg tablets and in an oral solution.

In 2002, the New York Times ran an article pointing out that Pfizer had promoted the use of Neurontin for nearly a dozen off-label uses. That same year, the consumer watchdog group Public Citizen called Neurontin, “the most complete and well-documented case of off-level promotion to ever come into public view.”

Two years later, Pfizer later pled guilty to the charge of illegally marketing the drug. Some of the off label uses the company had promoted Neurontin for include: bipolar disorder, amyotrophic lateral sclerosis (ALS -- or Lou Gehrig's disease), attention deficit disorder (ADD), substance abuse withdrawal and restless leg syndrome. Pfizer admitted that it had used an illegal marketing strategy to promote Neurontin for “off-label” and untested uses with no indication that the drug was effective in the treatment of those conditions. If you were prescribed Neurontin for off-label usage, call a medical a pharmaceutical attorney for legal advice.

As a result, Pfizer was fined $240 million. It also had to confront an avalanche of lawsuits by angry patients who felt that they had been deceived and their lives put at needless risk. Our Neurontin lawyers, personal injury attorneys, pharmaceuticla lawyers, and medical malpractice attorneys can help you seek financial retribution for your damages and medical costs.

Although, Pfizer no longer markets Neurontin (the drug is now off-patent and available in generic form), the company is still fighting lawsuits relating to its deceptive practices and false advertising of the drug. Neurontin lawyers and pharmaceutical attorney can assist you in receiving reimbursement for off-label usage.

In June, 2008, the Food and Drug Administration (FDA) directed the makers of 11 epilepsy drugs -- including Neurontin -- to add new warnings to their labels about the potential danger of suicidal thoughts and behavior. If you or a loved one experienced adverse effects from Neurontin, our drug effects lawyers and personal injury attorneys can help you pursue legal action.

Common side effects of Neurontin – whether used off label or as FDA approved -- are:

  • For Adults: dizziness, fatigue, sleepiness, vision problems, swelling of hands or feet, clumsiness, uncontrolled eye movement, diarrhea, headache, alcohol intolerance, sore throat or fever, memory loss, mood changes, difficult breathing, trembling or shaking, severe anxiety, weakness and suicidal tendency.
  • For Children (ages 3 – 12): viral infection, fever, nausea, vomiting, restlessness, behavior problems, mood swings, hyperactivity, aggression, lack of concentration, sleepiness, dizziness, headache, crying, convulsions, memory loss, diarrhea and suicidal tendency.
If you experienced adverse effects from using neurontin, contact a qualified drug effects lawyer, Neurontin lawyer, or pharmaceutical attorney.
 
Who Can Sue

If you or a loved one were prescribed Neurontin for off-label uses, or even if you took Neurontin for an FDA approved use and suffered serious side effects linked to your treatment, you may be eligible for compensation. Drug effects attorney, personal injury lawyers, and pharmaceutical attorneys can get your deserved compensation.

Plaintiffs in cases like this typically seek to recover damages for medical expenses, lost wages – both past and future -- and pain and suffering.

Only a qualified drug effects lawyer, persona injury attorney, or pharmaceutical lawyer can quickly review the facts of your case and tell you if you are eligible to seek damages.

While various Neurontin class actions are currently seeking court approval, an attorney who is familiar with the developing litigation can advise you on whether you would be better served by joining a ‘class’ group or pursuing your own individual lawsuit.

Should you experience thoughts of suicide or any other dangerous side effects associated with Neurontin use, contact your doctor at once. A physician can determine if it is safe for you to continue taking Neurontin.

If you or a loved one experience adverse effects from Neurontin use, contact a pharmaceutical lawyer, personal injury attorney, Neurontin lawyer, or drug effects attorney immediately.

Interesting Facts

Pfizer is the largest pharmaceutical manufacturer in the world.

Epilepsy affects about 100 million people worldwide. It is a disorder of the nervous system in which clusters of brain cells sometimes signal electrochemical disturbances which can cause seizures.

Approximately 30% of those with epilepsy have a severe form of the disease that results in more than 100 seizures per day.Seizures may be brought on by triggers, such as lack of sleep or a high level of stress. Certain persons are more prone to having seizures than others; however, the actual cause of seizures is unknown.There are four basic types of epileptic seizures:
  • Petit mal - a mild seizure involving dizziness, disorientation or staring into space.
  • Grand mal - a seizure in which there are severe convulsions and loss of consciousness or coma.
  • Jacksonian – spasms limited to one side of the body or to one group of muscles. People experiencing this type of seizure will remain awake and alert throughout.
  • Psychomotor – the person engages in motor acts which he or she cannot remember afterwards.

Postherpetic neuralgia (PHN) follows an outbreak of herpes zoster (shingles), which comes from the reactivation of the chickenpox virus. Sufferers experience pain ranging from mild to severe. Some people feel pain all the time and with others, it comes and goes.

Our pharmaceutical attorneys and personal injury lawyers can help you seek financial assistance to cover the medical costs of unnecessary doctor visits as a result of Neurontin use.

Potential Recovery

$430-million: On May 13, 2004, Pfizer agreed to plead guilty to charges of falsely marketing Neurontin and defrauding the federal government. The lawsuit was brought on after a whistle blower at the drug company testified about the company’s deliberate scheme to market Neurontin for unapproved uses. After Pfizer paid out $430 million in criminal and civil fines, it may have assumed that its legal problems were over. But that has not been the case. 

Later in 2004, a New York law firm filed a petition asking the FDA to act on claims that Neurontin is tied to suicidal behavior. The firm presented a list of 160 suicides and 2,000 attempted suicides by people who were taking Neurontin for a variety of ailments.

In June 2007, a third Amended Class Action lawsuit was filed against Pfizer, accusing the company of a fraudulent scheme to market and sell Neurontin for "off-label" uses. The suit alleged that in1995, the company decided it did not want to perform the necessary FDA clinical trials in order to obtain approval for Neurontin’s new uses. So instead, it created an illegal promotional campaign. This campaign allegedly included cash kickbacks to physicians and other tactics to pump up Neurontin’s off-label sales.

In October, 2008, a lawsuit -- brought by the same attorney who represented the original company whistle blower -- alleged that not only did Pfizer and its subsidiaries push Neurontin for unapproved uses, but they did so knowing the drug was ineffective at treating some of those conditions. The suit accuses Pfizer of publishing false or misleading scientific studies in order to make the drug appear effective when it was not. It also alleges that the company manipulated drug trial data in order to enhance Neurontin’s effectiveness and increase its sales.

No information on individual Neurontin settlements or jury awards is available at this time.

News

Neurontin and Off-Label Marketing

Drugmaker admitted fraud, but sales flourish

Pfizer's Headache: Lawsuit charges drugmaker was deceptive about Neurontin.

F.D.A. Links Drugs to Being Suicidal

 

Sponsored Links
 

WhoCanISue.comPharmaceuticalNeurontin

Copyright ©2014 WCIS Media, LLC. All rights reserved
Site Design, Search Engine Optimization, & Content provided by Digital Footprint Media.
 
VOIP & Data Services Provided by DLJ Management .
 
The content contained on the web site has been prepared for WCIS Media LLC as a value-add service to it’s legal and medical professionals network, in addition to it’s internet community and in no way is it intended to constitute legal advice or a substitute for consultation with a licensed legal professional in a particular case or circumstance.